Diploma PLC (LON:DPLM - Get Free Report) insider Chris Davies bought 3,917 shares of the business's stock in a transaction on Friday, December 20th. The stock was purchased at an average cost of GBX 4,280 ($53.80) per share, for a total transaction of £167,647.60 ($210,718.45).

Shares of LON DPLM opened at GBX 4,260 ($53.54) on Monday. The stock's 50-day moving average is GBX 4,409.37 and its two-hundred day moving average is GBX 4,325.84. The company has a debt-to-equity ratio of 45.69, a current ratio of 2.27 and a quick ratio of 0.80. The company has a market cap of £5.71 billion, a price-to-earnings ratio of 4,953.49, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. Diploma PLC has a 1-year low of GBX 3,200 ($40.22) and a 1-year high of GBX 4,653 ($58.48).

The company also recently announced a dividend, which will be paid on Friday, January 31st. Investors of record on Thursday, January 16th will be issued a GBX 42 ($0.53) dividend. This is a boost from Diploma's previous dividend of $17.30. The ex-dividend date of this dividend is Thursday, January 16th. This represents a yield of 0.93%. Diploma's dividend payout ratio (DPR) is 6,627.91%.

Several research firms recently issued reports on DPLM. JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 4,150 ($52.16) to GBX 4,370 ($54.93) and gave the company a "neutral" rating in a report on Thursday, December 5th. Shore Capital lowered shares of Diploma to a "hold" rating in a research note on Tuesday, November 19th. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 5,100 ($64.10) price objective on shares of Diploma in a report on Friday, November 22nd. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Diploma currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 4,555 ($57.25).

View Our Latest Analysis on Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Diploma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.

While Diploma currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.